About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Calculate anion gap first: AG = Na - (Cl + HCO3)
- High AG causes include lactate, ketoacidosis, renal failure, salicylates, methanol, ethylene glycol
- Non-AG causes include diarrhea, renal tubular acidosis, saline, acetazolamide
- Use Winter formula: expected PaCO2 = 1.5 x HCO3 + 8 +/- 2
- Treat the cause; bicarbonate is selective, not reflexive
Overview
Metabolic Acidosis (AG & non-AG) is a core renal/urologic USMLE Step 2 CK topic. The practical framework is to identify the syndrome, recognize dangerous red flags, choose the correct first-line investigation, and select the next best step using US-facing guidance. High-yield questions often hinge on urine microscopy, electrolyte patterns, imaging choice, medication exposures, obstruction, sepsis, malignancy risk, or dialysis indications.
Epidemiology
In US clinical practice, metabolic acidosis (ag & non-ag) is shaped by age, diabetes, hypertension, CKD, medication exposure, infection risk, malignancy risk, and volume status. Step 2 CK commonly tests classic demographic patterns and trigger clues rather than obscure epidemiology, so risk factors and context should be interpreted alongside the urinalysis, BMP, imaging, and clinical stability.
Clinical Features
Symptoms
Often asymptomatic early or detected by laboratory/imaging abnormality
Pain, urinary symptoms, constitutional symptoms, weakness, edema, or dyspnea may occur depending on severity
Fever, sepsis physiology, syncope, severe weakness, seizure, coma, pulmonary edema, or anuria are red flags
Hematuria, oliguria, persistent vomiting, or rapidly worsening symptoms require urgent assessment
Medication exposure, recent infection, obstruction symptoms, or systemic disease clues often identify the etiology
Signs
Assess volume status, blood pressure, fever, abdominal/flank findings, and cardiopulmonary signs
Urine output, CVA tenderness, bladder distension, prostate findings, edema, and rash can localize disease
ECG changes, altered mental status, pulmonary edema, hypotension, or peritoneal signs are emergencies
A normal examination does not exclude clinically important renal, electrolyte, or urologic disease
Investigations
First-line
BMP with creatinine, electrolytes, and bicarbonateDefines kidney function, electrolyte severity, acid-base pattern, and immediate safety issues
Urinalysis with microscopyScreens for hematuria, proteinuria, pyuria, casts, crystals, and infection clues
Medication and exposure reviewIdentifies nephrotoxins, RAAS blockers, diuretics, antibiotics, NSAIDs, contrast, toxins, and supplements
Targeted ECG or imagingUse ECG for potassium emergencies; ultrasound for obstruction/pregnancy; CT protocols for stones or malignancy when indicated
Second-line
CBC and inflammatory markersUseful when infection, malignancy, bleeding, or systemic inflammatory disease is suspected
Urine electrolytes, osmolality, culture, or protein quantificationClarifies renal physiology, volume status, infection, and glomerular involvement
Disease-specific serology or chemistryUse complement/autoantibodies for glomerulonephritis, CK for rhabdomyolysis, calcium/uric acid for stones, and cytology/biopsy for malignancy when indicated
Specialist
Nephrology or urology evaluationIndicated for refractory electrolyte disturbance, AKI, obstruction, malignancy, nephrotic/nephritic syndrome, dialysis planning, or uncertain diagnosis
Definitive procedure or biopsyUse when diagnosis or source control requires tissue, drainage, cystoscopy, decompression, angiography, or dialysis access
1
Immediate priorities
- Identify instability: sepsis, shock, pulmonary edema, ECG changes, neurologic symptoms, obstruction, or uremic complications
- Stabilize first; do not wait for confirmatory tests when classic emergency features are present
- Stop offending medications and correct volume status safely
2
Definitive management
- Treat the underlying cause according to US guideline-based practice
- Use nephrology/urology consultation when disease is severe, recurrent, obstructive, malignant, or rapidly progressive
- Monitor response with symptoms, urine output, creatinine, electrolytes, and targeted follow-up tests
3
Prevention and follow-up
- Reduce recurrence risk by managing BP, diabetes, smoking, nephrotoxins, diet, hydration, infection risks, and medication safety
- Arrange surveillance after malignancy, CKD, stones, glomerular disease, or dialysis access creation
- Educate patients on red flags requiring urgent reassessment
Complications
- Kidney injury or progression: Delayed recognition can cause AKI, CKD progression, or kidney failure
- Electrolyte and acid-base complications: Potassium, sodium, bicarbonate, and volume disorders can become life-threatening
- Infection, obstruction, thrombosis, or malignancy: Source control, imaging, or specialist intervention may be required
- Cardiovascular risk: Renal disease amplifies hypertension, heart failure, arrhythmia, and vascular risk
USMLE Step 2 CK Exam Tips
- 1Calculate anion gap first: AG = Na - (Cl + HCO3)
- 2High AG causes include lactate, ketoacidosis, renal failure, salicylates, methanol, ethylene glycol
- 3Non-AG causes include diarrhea, renal tubular acidosis, saline, acetazolamide
- 4Use Winter formula: expected PaCO2 = 1.5 x HCO3 + 8 +/- 2
- 5Treat the cause; bicarbonate is selective, not reflexive
- 6Next best step questions usually test stability first, then the localizing diagnostic clue
- 7Do not treat a lab number alone when the stem contains ECG changes, obstruction, sepsis, or uremic complications
practicetest your knowledge on metabolic acidosis (ag & non-ag)Apply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — renal and beyond.
open q-bank